18497162. CELL CULTURE COMPOSITIONS AND METHODS FOR POLYPEPTIDE PRODUCTION simplified abstract (Genentech, Inc.)

CELL CULTURE COMPOSITIONS AND METHODS FOR POLYPEPTIDE PRODUCTION

Organization Name

Genentech, Inc.

Inventor(s)

Natarajan Vijayasankaran of South San Francisco CA (US)

Steven J. Meier of South San Francisco CA (US)

Melissa S. Mun of South San Francisco CA (US)

Sharat Varma of South San Francisco CA (US)

Yi Yang of South San Francisco CA (US)

Boyan Zhang of South San Francisco CA (US)

Silvana R. Arevalo of South San Francisco CA (US)

Martin Gawlitzek of South San Francisco CA (US)

Veronica Carvalhal of South San Francisco CA (US)

CELL CULTURE COMPOSITIONS AND METHODS FOR POLYPEPTIDE PRODUCTION - A simplified explanation of the abstract

This abstract first appeared for US patent application 18497162 titled 'CELL CULTURE COMPOSITIONS AND METHODS FOR POLYPEPTIDE PRODUCTION

Simplified Explanation

The abstract of the patent application describes the provision of cell culture media for cell growth and polypeptide production, along with compositions comprising polypeptides produced by the methods.

• Cell culture media provided for cell growth and polypeptide production
• Methods for using the media for cell culture and polypeptide production
• Compositions comprising polypeptides produced by the methods

Potential Applications

The technology can be applied in various fields such as biotechnology, pharmaceuticals, and research laboratories for cell culture and polypeptide production.

Problems Solved

This technology addresses the need for optimized cell culture media for efficient cell growth and polypeptide production.

Benefits

The benefits of this technology include improved cell culture conditions, enhanced polypeptide production, and potentially increased efficiency in research and development processes.

Potential Commercial Applications

The technology can be commercially applied in biopharmaceutical companies, research institutions, and biotechnology firms for the production of antibodies and other polypeptides.

Possible Prior Art

Prior art may include existing cell culture media formulations, methods for cell culture, and polypeptide production techniques that have been previously patented or published.

How does this technology compare to existing cell culture media formulations in terms of efficiency and cost-effectiveness?

This article does not provide a direct comparison with existing cell culture media formulations in terms of efficiency and cost-effectiveness. Further research or comparative studies may be needed to address this question.

What are the specific polypeptides that can be produced using this technology, and are there any limitations in terms of polypeptide diversity or yield?

The article does not specify the types of polypeptides that can be produced using this technology or any limitations in terms of polypeptide diversity or yield. Additional information or studies may be required to answer this question.

Original Abstract Submitted

Cell culture media, such as chemically defined cell culture media, are provided, as are methods of using the media for cell growth (i.e., cell culture) and polypeptide (e.g., antibody) production. Compositions comprising polypeptides produced by the methods are also provided.